Laboratoires Pierre Fabre

Laboratoires Pierre Fabre (Template:IPA) is a French multinational pharmaceutical and cosmetics company headquartered in the city of Castres, Midi-Pyrénées, France.<ref name="france24">Template:Cite news</ref>

History

Founded in 1962 by Pierre Fabre (1926-2013),<ref name="france24" /> the company is present in over 130 countries.

Olivier Bohuon was Chief Executive from September 2010 to April 2011.<ref>Template:Cite web</ref>

Business

The company's business activity is focused on research, development, manufacturing and marketing of cosmetics, prescription medicines and family health products.

Pharmaceuticals and phytotherapy represent 47% of turnover, whereas cosmetics represent 53% (percentages of 2012 turnover).Template:Citation needed

The company had a consolidated turnover of 1.978 billion euros in 2012 (including 54% international).<ref name="france24" />

Laboratories Pierre Fabre had approximately 10,000 employees in 2012, 33% of whom are internationally based, while the remaining 6,700 employees were based in France.<ref name="france24" />

Products

Pierre Fabre is best known for its vinorelbine (Navelbine),<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> an anticancer drug<ref>Template:Cite journal</ref> of the vinca alkaloid class.<ref>Template:Cite journal</ref><ref>Template:Cite book</ref><ref>Template:Cite book</ref>

They also developed vinflunine,<ref>Template:Cite press release</ref> a fluorinated vinca alkaloid derivative<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref> available in Australia for "advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinum containing regimen."<ref>Template:Cite web</ref>

The Pierre Fabre Foundation

The Pierre Fabre Foundation was recognized as a public utility in 1999,<ref>Template:Cite web</ref> and its mission is to enable communities from less advanced and emerging countries, as well as those plunged into severe crisis by political or economic upheaval and/or natural disaster, to access the quality and levels of everyday health care and the widely-used drugs defined by the WHO and other organisations as essential to human health.<ref>Template:Cite web</ref>

External links

• Template:In lang Pierre Fabre laboratories - Official site

Template:Med-company-stub